Ignite Creation Date:
2024-07-17 @ 10:51 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06495515
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-03
Brief Title:
Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced First-line HR Positive and HER2 Negative Breast Cancer a Multicenter Single Arm Exploratory Phase II Clinical Study
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-03
First Submit QC Date:
None
Study First Post Date:
2024-07-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-03
Last Update Post Date:
2024-07-10
Last Update Post Date Type:
ACTUAL